Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.

Kim MJ, Choi NY, Lee EK, Kang MS.

Cell Oncol (Dordr). 2014 Aug;37(4):235-43. doi: 10.1007/s13402-014-0178-4. Epub 2014 Jul 8.

PMID:
25001871
2.

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.

Breast Cancer Res. 2008;10(4):R69. doi: 10.1186/bcr2131. Epub 2008 Aug 7.

PMID:
18687126
3.

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.

Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.

Acta Oncol. 2011 Jun;50(5):700-10. doi: 10.3109/0284186X.2010.549151. Epub 2011 Jan 24.

PMID:
21261508
4.

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Onstenk W, Kraan J, Mostert B, Timmermans MM, Charehbili A, Smit VT, Kroep JR, Nortier JW, van de Ven S, Heijns JB, Kessels LW, van Laarhoven HW, Bos MM, van de Velde CJ, Gratama JW, Sieuwerts AM, Martens JW, Foekens JA, Sleijfer S.

Mol Cancer Ther. 2015 Mar;14(3):821-7. doi: 10.1158/1535-7163.MCT-14-0653. Epub 2014 Dec 31.

PMID:
25552367
5.

EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.

Ring A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE.

Oncotarget. 2015 Dec 29;6(42):44623-34. doi: 10.18632/oncotarget.5977.

PMID:
26556851
6.

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

Weissenstein U, Schumann A, Reif M, Link S, Toffol-Schmidt UD, Heusser P.

BMC Cancer. 2012 May 30;12:206. doi: 10.1186/1471-2407-12-206.

PMID:
22646670
7.

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein NH, Templin MF, Pawlak M, Fehm T, Neubauer H; Disseminated Cancer Cell Network (DCC Net) Duesseldorf.

PLoS One. 2015 Dec 22;10(12):e0144535. doi: 10.1371/journal.pone.0144535. eCollection 2015. Erratum in: PLoS One. 2016;11(2):e0149315.

PMID:
26695635
8.

The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.

de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ, Terstappen LW.

Sci Rep. 2015 Jul 17;5:12270. doi: 10.1038/srep12270.

PMID:
26184843
9.

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O.

BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.

PMID:
22591372
10.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

PMID:
24602188
11.

Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.

Johnson ES, Anand RK, Chiu DT.

Anal Chem. 2015 Sep 15;87(18):9389-95. doi: 10.1021/acs.analchem.5b02241. Epub 2015 Aug 31.

PMID:
26302174
12.

Circulating tumor cells and EpCAM expression in neuroendocrine tumors.

Khan MS, Tsigani T, Rashid M, Rabouhans JS, Yu D, Luong TV, Caplin M, Meyer T.

Clin Cancer Res. 2011 Jan 15;17(2):337-45. doi: 10.1158/1078-0432.CCR-10-1776. Epub 2011 Jan 11.

PMID:
21224371
13.

Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.

Guo W, Yang XR, Sun YF, Shen MN, Ma XL, Wu J, Zhang CY, Zhou Y, Xu Y, Hu B, Zhang X, Zhou J, Fan J.

Clin Cancer Res. 2014 Sep 15;20(18):4794-805. doi: 10.1158/1078-0432.CCR-14-0251. Epub 2014 Jul 9.

PMID:
25009297
14.

Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q.

Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2.

PMID:
22990361
15.

EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.

Chikaishi Y, Yoneda K, Ohnaga T, Tanaka F.

Oncol Rep. 2017 Jan;37(1):77-82. doi: 10.3892/or.2016.5235. Epub 2016 Nov 8.

PMID:
27840987
16.

Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).

Myung JH, Launiere CA, Eddington DT, Hong S.

Langmuir. 2010 Jun 1;26(11):8589-96. doi: 10.1021/la904678p.

PMID:
20155985
17.

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R.

BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.

PMID:
21129172
18.

Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.

Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK.

Cytometry A. 2015 Feb;87(2):137-44. doi: 10.1002/cyto.a.22613. Epub 2014 Dec 16.

PMID:
25515318
19.

Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.

Grover PK, Cummins AG, Price TJ, Roberts-Thomson IC, Hardingham JE.

Ann Oncol. 2014 Aug;25(8):1506-16. doi: 10.1093/annonc/mdu018. Epub 2014 Mar 20. Review.

PMID:
24651410
20.

Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.

Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, Cathcart P, Hines J, Shamash J, Lu YJ.

PLoS One. 2015 Sep 23;10(9):e0138032. doi: 10.1371/journal.pone.0138032. eCollection 2015.

PMID:
26397728

Supplemental Content

Support Center